DUBLIN--(BUSINESS WIRE)--The "China Companion Animal Health Market Size, Share & Trends Analysis Report by Type (Medicine, Diagnostics), Animal Type (Dogs, Cats), Diagnosis Method, Product, Indication, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com's offering.

The China companion animal health market size is anticipated to reach USD 2.24 billion by 2028 and is expected to grow at a CAGR of 11.3% from 2021 to 2028.

The key factors driving the market growth include rising initiatives by key market players, a growing pet population, and high usage of e-commerce channels.

The COVID-19 pandemic had a significant impact on the market in 2020. The adverse effects of the pandemic include supply chain bottlenecks, decreased sales & marketing initiatives, and dampened demand. However, pet ownership and expenditure continued to rise in the country during 2020.

Even during the pandemic, online sales of the pet industry showed accelerated growth after an initial slump, as reported by China Daily. Key factors identified for this growth include increasing per capita GDP and pet humanization. For instance, according to the World Bank estimates, per capita GDP in China, in 2020, was USD 10,500, notably greater than the per capita GDP of USD 8,066 in 2015 and USD 4,550 in 2010.

The rising pet population in China is a key factor driving the market growth. The RADII Media reported that in 2020, the popularity of cats as pets was growing rapidly across China. The main reason identified for this trend was cats being relatively low-maintenance pets as compared to pet dogs.

As per the Shanghai United Media Group, the preference for exotic and other companion animals is increasing among the young population in the country. Key factors fueling this growth include certain pets needing less upkeep as compared to dogs or horses. For example, geckos or small mammals require much less space, energy, and time from the pet owner as compared to mainstream pets.

Increasing usage of online channels for purchasing pet products is anticipated to propel the market in the coming years. China Daily reported that in 2019, online sales of the pet industry crossed 30 billion Yuan, or about USD 4.3 billion. 70% of the total sales were accounted for by e-commerce giants, such as Tmall and Taobao, as reported at Pet Fair Asia 2020. Key market players leveraged this opportunity to strengthen their market presence.

In February 2019, Boehringer Ingelheim, for instance, launched the first-of-its-kind flagship store by a multinational animal health company on Tmall for pet parasiticides. The store was launched to provide customers with a reliable and convenient online purchasing channel for the company's full range of pet parasiticides.

China Companion Animal Health Market Report Highlights

• The companion animal medicine segment accounted for the highest share of the market in 2020 owing to the increased awareness about pet health and the high prevalence of diseases in pets
• Dogs represented the largest segment by animal type for both companion animal medicine as well as diagnostics markets in 2020
• By indication, non-infectious diseases dominated the China pet medicine as well as diagnostics markets in 2020
• The growth can be credited to the high awareness about animal health & diseases and increased pet expenditure & pet humanization
• Global trends, such as the One Health initiative, are expected to further propel awareness about animal health and boost the demand for medicines and diagnostics products for pets
• In June 2020, the World Bank Group approved a loan of USD 300 million to help strengthen select national and provincial systems in China to lower the risk of zoonoses and other emerging health threats as part of the Emerging Infectious Diseases Prevention, Preparedness and Response Project

China Companion Animal Health Market Variables, Trends & Scope

• Market Lineage Outlook
• Penetration & Growth Prospect Mapping, 2020
• China Companion Animal Health Market Dynamics
• China Companion Animal Health Market Analysis Tools: Porter's
• China Companion Animal Health Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
• Unmet Needs in Companion Animal Health Market
• Pet Drug Development Analysis
• Pipeline analysis
• Access Path of Pet Medicine Market (U.S., Europe, APAC)
• Regulatory Scenario for Drug Approval
• Market Entry Strategies

Companies Mentioned

• Boehringer Ingelheim International GmbH
• Elanco
• Merck & Co. Inc.
• Zoetis
• Ceva
• Virbac
• Bimeda, Inc.
• IDEXX Laboratories
• Thermo Fisher Scientific
• Randox Laboratories

For more information about this report visit https://www.researchandmarkets.com/r/b9j62t

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900